help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bomboy, J. D.
Right arrow Articles by Liljenquist, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bomboy, J. D.
Right arrow Articles by Liljenquist, J. E.

Journal of Clinical Endocrinology & Metabolism, Vol 44, 474-480, Copyright © 1977 by Endocrine Society


ARTICLES

Insulin-glucagon interaction in controlling splanchnic glucose production in normal man

JD Bomboy, SB Lewis, BC Sinclair-Smith, WW Lacy and JE Liljenquist

The interaction of glucagon and insulin in controlling hepatic glucose production in man has been inferred from studies of immunoreactive glucagon and insulin. This study directly examines the interaction of glucagon and insulin in controlling net splanching glucose production (NSGP) in eight normal men. Glucagon was infused iv at 5 ng/kg/min for 15 min and resultant arterial glucagon levels (1.3 X 10(-10) M) did not exceed the physiologic portal range. In four normal men NSGP increased 2.3-fold by 5 min and remained elevated for 15 min. There was no change in arterial insulin concentration. To study the effect of exogenous insulin on this glucagon-induced increase in NSGP, insulin was infused at 10 mU/kg/min in four normal men to achieve arterial immunoreactive insulin concentrations of 1500 muU/ml (1 X 10(-8) M). Blood glucose was stabilized by glucose infusions. During insulin and glucose administration, NSGP was suppressed and net splanchnic glucose uptake occurred. After 40 min of insulin and glucose pretreatment, a 5 ng/kg/min glucagon infusion resulted in no increase in NSGP (arterial insulin: glucagon molar ratio of approximately 100). In two subjects the glucagon infusion rate was then increased to 15 ng/kg/min (arterial insulin: glucagon molar ratio of approximately 33), resulting in stimulation of NSGP. These studies provide evidence that insulin in high concentration can suppress glucagon-stimulated NSGP in normal man.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
B. E. Dunning and J. E. Gerich
The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications
Endocr. Rev., May 1, 2007; 28(3): 253 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
V. M. Bonjorn, M. G. Latour, P. Belanger, and J.-M. Lavoie
Influence of prior exercise and liver glycogen content on the sensitivity of the liver to glucagon
J Appl Physiol, January 1, 2002; 92(1): 188 - 194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society